Skip page top navigationFDA Logo--links to FDA home page Logo of and Link to start page of Office of Regulatory Affairs, U.S. Food and Drug Administration U.S. Food and Drug Administration Office of Regulatory Affairs HHS Logo and link to Department of Health and Human Services website

FDA Home Page | Federal-State | Import Program | Compliance | Inspection | Science | ORA Search  Vignette Managed Content: Click here for Metadata

Inspection References
Investigations Operations Manual 2008
Previous Page | Document TOC | Chapter TOC | Next Page

Contents

2.1 - REGULATORY NOTES
2.1.1 - USES OF REGULATORY NOTES
2.1.2 - REGULATORY NOTES CHARACTERISTICS
2.1.3 - REGULATORY ENTRIES
2.1.4 - FORMAT FOR REGULATORY NOTES
2.1.5 - RETENTION OF REGULATORY NOTES
2.2 - STATUTORY AUTHORITY
2.2.1 - FEDERAL FOOD, DRUG, AND COSMETIC ACT
     2.2.1.1 - Authority to Enter and Inspect
     2.2.1.2 - Food Inspections
     2.2.1.3 - Device Inspections
     2.2.1.4 - Limitations
     2.2.1.5 - Electronic Radiation Product Examinations and Inspections
2.2.2 - SELECTED AMENDMENTS TO THE FD&C ACT
2.2.3 - OTHER ACTS
     2.2.3.1 - Anabolic Steroids Control Act of 1990
     2.2.3.2 - Fair Packaging and Labeling Act (FPLA)
     2.2.3.3 - Federal Anti-Tampering Act
     2.2.3.4 - Federal Import Milk Act
     2.2.3.5 - Federal Caustic Poison Act
     2.2.3.6 - Poison Prevention Packaging Act
     2.2.3.7 - Public Health Service Act (PHS)
     2.2.3.8 - Mammography Quality Standards Act of 1992
2.2.4 - CODE OF FEDERAL REGULATIONS (CFR)
2.2.5 - DEFINITIONS
     2.2.5.1 - Civil Number
     2.2.5.2 - Citation (Cite)
     2.2.5.3 - Criminal Number
     2.2.5.4 - FDC and INJ Numbers
     2.2.5.5 - Complaint For Forfeiture
     2.2.5.6 - Home District
     2.2.5.7 - Nolle Prosequi (Nol-Pros)
     2.2.5.8 - Nolo Contendere (Nolo)
     2.2.5.9 - Seizing District
     2.2.5.10 - Subpoena Duces Tecum
     2.2.5.11 - Supervising District
2.2.6 - SEIZURE
     2.2.6.1 - District Recommendation
     2.2.6.2 - Headquarters
     2.2.6.3 - Department of Justice
     2.2.6.4 - U.S. District Court
     2.2.6.5 - Claimant and Options
     2.2.6.6 - Abandonment
     2.2.6.7 - Reconditioning for Compliance
     2.2.6.8 - Contested Seizure
     2.2.6.9 - District Follow-up
2.2.7 - PROSECUTION
     2.2.7.1 - Section 305 Notice
     2.2.7.2 - Information
     2.2.7.3 - Grand Jury Proceedings
     2.2.7.4 - District Follow-up
2.2.8 - INJUNCTION
     2.2.8.1 - Temporary Restraining Order (TRO)
     2.2.8.2 - Hearing for Injunction
     2.2.8.3 - Consent Decree of Injunction
     2.2.8.4 - Trial for Injunction
     2.2.8.5 - Preliminary or Permanent Injunction
     2.2.8.6 - District Follow-up
2.2.9 - EMERGENCY PERMIT CONTROL
2.2.10 - DETENTION POWERS
2.2.11 - COURTROOM TESTIMONY
     2.2.11.1 - Testimony Preparation
     2.2.11.2 - Interviewing Persons Under Arrest
2.3 - RECONDITIONING AND DISTRUCTION
2.3.1 - DEFINITIONS
     2.3.1.1 - Reconditioning
     2.3.1.2 - Destruction
     2.3.1.3 - Denaturing
2.3.2 - DISASTERS
2.4 - CONSENT DECREE
2.4.1 - POLICY
2.4.2 - RELABELING
2.4.3 - REWORKING
2.4.4 - SEGREGATION
2.4.5 - DESTRUCTION
2.4.6 - DISPOSITION OF REJECTS
2.4.7 - RELEASE OF GOODS
2.4.8 - REPORTING
2.5 - DEFAULT DECREE
2.5.1 - POLICY
2.5.2 - REPORTING
2.6 - COMPLIANCE ACHIEVEMENT
2.6.1 - POLICY
2.6.2 - DESTRUCTION
     2.6.2.1 - DEA Controlled Drugs
        2.6.2.1.1 - DEA Approval
        2.6.2.1.2 - Procedure
2.6.3 - RECONDITIONING
2.6.4 - REPORTING
     2.6.4.1 - Documenting Voluntary Destruction
     2.6.4.2 - Compliance Achievement Reporting
        2.6.4.2.1 - Violative Products
        2.6.4.2.2 - Destruction by Cooperating Officials
        2.6.4.2.3 - Manufacturer's Raw Materials
        2.6.4.2.4 - Capital Improvements
        2.6.4.2.5 - Correction of GMP Deviations
        2.6.4.2.6 - Formula/Label Correction
        2.6.4.2.7 - Additional Personnel
        2.6.4.2.8 - Educational and/or Training
        2.6.4.2.9 - Items Not Reported in FACTS
2.7 - DETENTION ACTIVITIES
2.7.1 - OVERVIEW AND AUTHORITY
     2.7.1.1 - Overview
        2.7.1.1.1 - Accomplishing a Detention
        2.7.1.1.2 - Detention Of Medical Devices
        2.7.1.1.3 - Detention of Foods
        2.7.1.1.4 - Detention Procedural Steps
     2.7.1.2 - Authorities
        2.7.1.2.1 - Food Drug and Cosmetic Act
        2.7.1.2.2 - Federal Meat Inspection Act
        2.7.1.2.3 - Poultry Products Inspection Act
        2.7.1.2.4 - Egg Products Inspection Act
     2.7.1.3 - Definitions
        2.7.1.3.1 - Device
        2.7.1.3.2 - FOOD
        2.7.1.3.3 - PERISHABLE FOOD
        2.7.1.3.4 - MEAT PRODUCTS AND POULTRY PRODUCTS (DUAL JURISDICTION)
        2.7.1.3.5 - EGG AND EGG PRODUCTS (DUAL JURISDICTION)
2.7.2 - INSPECTIONAL PROCEDURE
     2.7.2.1 - Criteria for Detention
        2.7.2.1.1 - Devices
        2.7.2.1.2 - FOOD
        2.7.2.1.3 - Meat and Poultry Products
        2.7.2.1.4 - Egg and Egg Products
     2.7.2.2 - Detention Procedure
        2.7.2.2.1 - CONSIDERATIONS
        2.7.2.2.2 - EXECUTING the Detention
     2.7.2.3 - Detention Notice FDA 2289
        2.7.2.3.1 - Preparation of Detention Notice
        2.7.2.3.2 - Preparation of Page 1 (FDA 2289)
        2.7.2.3.3 - Preparation of Page 2 through 5 (FDA-2289)
        2.7.2.3.4 - Distribution of FDA-2289
     2.7.2.4 - Detention Tag FDA 2290
        2.7.2.4.1 - Preparation
        2.7.2.4.2 - Front of Tag
        2.7.2.4.3 - Reverse of Tag
        2.7.2.4.4 - Use of Tag
     2.7.2.5 - Termination of Detention
        2.7.2.5.1 - Removal of Detention Tags
        2.7.2.5.2 - Issuance of Detention Termination Notice FDA 2291
2.7.3 - SAMPLING
2.7.4 - SUPERVISION OF RECONDITIONING, DENATURING, OR DESTRUCTION
2.7.5 - REPORTING
2.8 - DENATURING
2.8.1 - OBJECTIVE
2.8.2 - DIVERSION TO ANIMAL FEED
     2.8.2.1 - Rodent or Bird Contaminated Foods
     2.8.2.2 - Moldy Food
     2.8.2.3 - Pesticide Contamination
2.8.3 - DECHARACTERIZATION FOR NON-FOOD OR FEED PURPOSES
2.9 - REGULATORY SUBMISSIONS
2.9.1 - CENTER FOR DRUG EVALUATION AND RESEARCH (CDER)
     2.9.1.1 - Registration and Listing
     2.9.1.2 - Investigational New Drug Application (IND)
     2.9.1.3 - New Drug Application (NDA)
     2.9.1.4 - Abbreviated New Drug Application (ANDA)
2.9.2 - CENTER FOR DEVICES AND RADIOLOGICAL HEALTH (CDRH)
     2.9.2.1 - Device Registration and Listing
     2.9.2.2 - Investigational Device Exemption (IDE) Regulation
     2.9.2.3 - Premarket Notification - Section 510(k)
     2.9.2.4 - Premarket Approval
     2.9.2.5 - Classification of Devices
        2.9.2.5.1 - Class I
        2.9.2.5.2 - Class II
        2.9.2.5.3 - Class III
     2.9.2.6 - Requests for GMP Exemption and Variances
     2.9.2.7 - Medical Device Reporting
     2.9.2.8 - Radiation Reporting
2.9.3 - CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER)
     2.9.3.1 - Registration and Listing
        2.9.3.1.1 - Human Blood and Blood Products
        2.9.3.1.2 - Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)
     2.9.3.2 - Biologic License
2.9.4 - CENTER FOR VETERINARY MEDICINE (CVM)
     2.9.4.1 - Registration and Listing
     2.9.4.2 - Medicated Feed Mill License (FML)
     2.9.4.3 - Abbreviated New Animal Drug Application (ANADA)
     2.9.4.4 - New Animal Drug Application (NADA)
2.9.5 - CENTER FOR FOOD SAFETY AND APPLIED NUTRITION (CFSAN)
     2.9.5.1 - Low Acid Canned Food (LACF) / Acidified Foods (AF) Food Canning Establishment (FCE) Registration
     2.9.5.2 - FCE Process Filing of LACF/AF Processors
     2.9.5.3 - Cosmetics
     2.9.5.4 - Color Certification Program
     2.9.5.5 - Infant Formula
     2.9.5.6 - Interstate Certified Shellfish (Fresh and Frozen Oysters, Clams, and Mussels) Shippers
     2.9.5.7 - Interstate Milk Shippers (IMS)
Page Top Previous Page | Document TOC | Chapter TOC | Next Page